Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

755 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma.
Nguyen TB, Sakata-Yanagimoto M, Fujisawa M, Nuhat ST, Miyoshi H, Nannya Y, Hashimoto K, Fukumoto K, Bernard OA, Kiyoki Y, Ishitsuka K, Momose H, Sukegawa S, Shinagawa A, Suyama T, Sato Y, Nishikii H, Obara N, Kusakabe M, Yanagimoto S, Ogawa S, Ohshima K, Chiba S. Nguyen TB, et al. Among authors: fukumoto k. Cancer Res. 2020 May 1;80(9):1875-1884. doi: 10.1158/0008-5472.CAN-19-2787. Epub 2020 Feb 27. Cancer Res. 2020. PMID: 32107212 Clinical Trial.
Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
Fujisawa M, Sakata-Yanagimoto M, Nishizawa S, Komori D, Gershon P, Kiryu M, Tanzima S, Fukumoto K, Enami T, Muratani M, Yoshida K, Ogawa S, Matsue K, Nakamura N, Takeuchi K, Izutsu K, Fujimoto K, Teshima T, Miyoshi H, Gaulard P, Ohshima K, Chiba S. Fujisawa M, et al. Among authors: fukumoto k. Leukemia. 2018 Mar;32(3):694-702. doi: 10.1038/leu.2017.273. Epub 2017 Aug 23. Leukemia. 2018. PMID: 28832024 Free PMC article.
Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
Tanzima Nuhat S, Sakata-Yanagimoto M, Komori D, Hattori K, Suehara Y, Fukumoto K, Fujisawa M, Kusakabe M, Matsue K, Wakamatsu H, Shimadzu M, Chiba S. Tanzima Nuhat S, et al. Among authors: fukumoto k. Cancer Sci. 2018 May;109(5):1682-1689. doi: 10.1111/cas.13557. Epub 2018 Mar 31. Cancer Sci. 2018. PMID: 29493850 Free PMC article.
Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status.
Shrestha R, Sakata-Yanagimoto M, Maie K, Oshima M, Ishihara M, Suehara Y, Fukumoto K, Nakajima-Takagi Y, Matsui H, Kato T, Muto H, Sakamoto T, Kusakabe M, Nannya Y, Makishima H, Ueno H, Saiki R, Ogawa S, Chiba K, Shiraishi Y, Miyano S, Mouly E, Bernard OA, Inaba T, Koseki H, Iwama A, Chiba S. Shrestha R, et al. Among authors: fukumoto k. Blood Adv. 2020 Mar 10;4(5):845-854. doi: 10.1182/bloodadvances.2019001324. Blood Adv. 2020. PMID: 32126143 Free PMC article.
VAV1 mutations contribute to development of T-cell neoplasms in mice.
Fukumoto K, Sakata-Yanagimoto M, Fujisawa M, Sakamoto T, Miyoshi H, Suehara Y, Nguyen TB, Suma S, Yanagimoto S, Shiraishi Y, Chiba K, Bouska A, Kataoka K, Ogawa S, Iqbal J, Ohshima K, Chiba S. Fukumoto K, et al. Blood. 2020 Dec 24;136(26):3018-3032. doi: 10.1182/blood.2020006513. Blood. 2020. PMID: 32992343 Free PMC article.
755 results